Tolerability Study of the Application of a 3M Microstructure Transdermal System



Status:Archived
Conditions:Healthy Studies
Therapuetic Areas:Other
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:November 2010
End Date:April 2011

Use our guide to learn which trials are right for you!

Tolerability Study of the Application of a 3M Microstructure Transdermal System by Finger Pressure to the Face in Healthy Subjects Stratified by Age and Fitzpatrick Skin Type


The purpose of this study is to evaluate the safety and tolerability of an experimental
device that introduces microscopic channels into the skin. Creating microscopic channels in
the skin allows for better absorption of various medications applied to the skin, and this
study will determine if the study device offers a tolerable method by which to introduce
these holes. The study population will include 54 individuals, ages 18-74 years old, with a
roughly equal distribution of skin colors. Each subject will have a total of three visits 24
hours apart from one another. The study device will be applied at the Baseline and Day 1
visits. At various timepoints before and after device application, skin assessments for
irritation will be completed using a 7-point Skin Reaction Scale and photographs will be
taken. Subjects will report pain associated with device application using a standardized
pain scale. At the baseline visit, a member of the research staff will administer
applications of the study device on the side of the subject's forehead, temple and the area
below and to the side of the nose on randomly selected sides of the face. The side of the
face at each location not receiving application of the study device will receive
applications of a "dummy" device. Subjects will not be informed of which device is the study
device and which is the "dummy" device. At the Day 1 visit, a member of the research staff
will administer study device applications to the center of the subject's forehead. The
subject will also self-apply the study device to the chin, under the instruction of the
research staff member. At the Day 2 visit, final skin assessments will be made and the
subject will be evaluated and treated for any persistent skin irritation. Differences in
skin irritation between sites of study device application and "dummy" device application
will be determined, as well as several other endpoints.



We found this trial at
1
site
201 East Huron Street
Chicago, Illinois 60611
(847) 491-3741
Northwestern University Northwestern is recognized both nationally and internationally for the quality of its educational...
?
mi
from
Chicago, IL
Click here to add this to my saved trials